Agile Therapeutics, Inc. Net Cash Provided by (Used in) Continuing Operations
Agile Therapeutics, Inc. reported Net Cash Provided by (Used in) Continuing Operations of -$7.01 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2017-05-08
- Agile Therapeutics, Inc. net cash provided by (used in) continuing operations for the quarter ending 2017-03-31 was -$7.01M, a 122.53% decline year-over-year.
- Agile Therapeutics, Inc. net cash provided by (used in) continuing operations for the quarter ending 2016-12-31 was -$2.92M.
- Agile Therapeutics, Inc. net cash provided by (used in) continuing operations for the quarter ending 2016-09-30 was -$7.55M.
- Agile Therapeutics, Inc. net cash provided by (used in) continuing operations for the quarter ending 2016-06-30 was -$6.27M.
- Agile Therapeutics, Inc. net cash provided by (used in) continuing operations for fiscal 2016 was $14.36M.
- Agile Therapeutics, Inc. net cash provided by (used in) continuing operations for fiscal 2015 was -$5.79M, a 115.20% decline from fiscal 2014.
- Agile Therapeutics, Inc. net cash provided by (used in) continuing operations for fiscal 2014 was $38.06M.
- Agile Therapeutics, Inc. net cash provided by (used in) continuing operations for fiscal 2013 was -$17.89M, a 271.21% decline from fiscal 2012.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Continuing Operations 12 month | Net Cash Provided by (Used in) Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-03-31 | -$7.01M 10-Q · filed 2017-05-08 | -$9.93M derived: sum of 2 quarters · filed 2017-05-08 | -$17.48M derived: sum of 3 quarters · filed 2017-05-08 | -$23.75M derived: sum of 4 quarters · filed 2017-05-08 | ||||
| 2016-12-31 | -$2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$10.47M derived: sum of 2 quarters · filed 2017-03-15 | -$16.75M derived: sum of 3 quarters · filed 2017-03-15 | $14.36M 10-K · filed 2017-03-15 | ||||
| 2016-09-30 | -$7.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$13.82M derived: sum of 2 quarters · filed 2016-11-07 | $17.27M 10-Q · filed 2016-11-07 | $12.27M derived: sum of 4 quarters · filed 2017-05-08 | ||||
| 2016-06-30 | -$6.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $24.83M 10-Q · filed 2016-08-08 | $19.82M derived: sum of 3 quarters · filed 2017-05-08 | $12.82M derived: sum of 4 quarters · filed 2017-05-08 | ||||
| 2016-03-31 | $31.10M 10-Q · filed 2017-05-08 | $26.09M derived: sum of 2 quarters · filed 2017-05-08 | $19.09M derived: sum of 3 quarters · filed 2017-05-08 | $11.63M derived: sum of 4 quarters · filed 2017-05-08 | ||||
| 2015-12-31 | -$5.01M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$12.01M derived: sum of 2 quarters · filed 2017-03-15 | -$19.47M derived: sum of 3 quarters · filed 2017-03-15 | -$5.79M 10-K · filed 2017-03-15 | ||||
| 2015-09-30 | -$7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$14.46M derived: sum of 2 quarters · filed 2016-11-07 | -$778.00K 10-Q · filed 2016-11-07 | -$777.83K 10-Q · filed 2015-11-09 | -$6.28M derived: sum of 4 quarters · filed 2017-03-15 | |||
| 2015-06-30 | -$7.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $6.22M 10-Q · filed 2016-08-08 | $6.23M 10-Q · filed 2015-08-13 | $726.77K derived: sum of 3 quarters · filed 2017-03-15 | -$7.09M derived: sum of 4 quarters · filed 2017-03-15 | |||
| 2015-03-31 | $13.68M 10-Q · filed 2016-05-09 | $13.68M 10-Q · filed 2015-05-12 | $8.18M derived: sum of 2 quarters · filed 2017-03-15 | $370.62K derived: sum of 3 quarters · filed 2017-03-15 | $50.85M derived: sum of 4 quarters · filed 2017-03-15 | |||
| 2014-12-31 | -$5.50M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$13.31M derived: sum of 2 quarters · filed 2017-03-15 | $37.17M derived: sum of 3 quarters · filed 2017-03-15 | $38.06M 10-K · filed 2017-03-15 | $38.06M 10-K · filed 2015-03-26 | |||
| 2014-09-30 | -$7.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $42.67M derived: sum of 2 quarters · filed 2015-11-09 | $43.56M 10-Q · filed 2015-11-09 | $41.74M derived: sum of 4 quarters · filed 2016-03-09 | ||||
| 2014-06-30 | $50.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $51.37M 10-Q · filed 2015-08-13 | $49.55M derived: sum of 3 quarters · filed 2016-03-09 | $45.30M derived: sum of 4 quarters · filed 2016-03-09 | ||||
| 2014-03-31 | $890.36K 10-Q · filed 2015-05-12 | -$934.41K derived: sum of 2 quarters · filed 2016-03-09 | -$5.18M derived: sum of 3 quarters · filed 2016-03-09 | |||||
| 2013-12-31 | -$1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | -$6.07M derived: sum of 2 quarters · filed 2016-03-09 | -$17.89M 10-K · filed 2016-03-09 | -$17.89M 10-K · filed 2015-03-26 | ||||
| 2013-09-30 | -$4.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$16.07M 10-Q · filed 2014-11-13 | ||||||
| 2013-06-30 | -$11.82M 10-Q · filed 2014-08-14 | |||||||
| 2012-12-31 | $10.45M 10-K · filed 2015-03-26 |